nodes	percent_of_prediction	percent_of_DWPC	metapath
Latanoprost—PTGFR—corpus luteum—ovarian cancer	0.232	0.416	CbGeAlD
Latanoprost—PTGFR—ovarian follicle—ovarian cancer	0.181	0.325	CbGeAlD
Latanoprost—Cystoid macular oedema—Paclitaxel—ovarian cancer	0.0367	0.0829	CcSEcCtD
Latanoprost—Cystoid macular oedema—Docetaxel—ovarian cancer	0.0311	0.0703	CcSEcCtD
Latanoprost—PTGFR—myometrium—ovarian cancer	0.0255	0.0457	CbGeAlD
Latanoprost—PTGFR—uterus—ovarian cancer	0.0165	0.0296	CbGeAlD
Latanoprost—Macular oedema—Paclitaxel—ovarian cancer	0.0158	0.0356	CcSEcCtD
Latanoprost—PTGFR—female reproductive system—ovarian cancer	0.0149	0.0266	CbGeAlD
Latanoprost—PTGFR—female gonad—ovarian cancer	0.0135	0.0242	CbGeAlD
Latanoprost—PTGFR—testis—ovarian cancer	0.012	0.0215	CbGeAlD
Latanoprost—SLCO2B1—decidua—ovarian cancer	0.0104	0.0187	CbGeAlD
Latanoprost—Dermatitis atopic—Chlorambucil—ovarian cancer	0.0101	0.0229	CcSEcCtD
Latanoprost—SLCO2B1—uterus—ovarian cancer	0.00911	0.0163	CbGeAlD
Latanoprost—Embolism—Vinorelbine—ovarian cancer	0.00891	0.0201	CcSEcCtD
Latanoprost—Dermatitis atopic—Melphalan—ovarian cancer	0.00884	0.02	CcSEcCtD
Latanoprost—PTGFR—lymph node—ovarian cancer	0.00869	0.0156	CbGeAlD
Latanoprost—SLCO2B1—female reproductive system—ovarian cancer	0.00819	0.0147	CbGeAlD
Latanoprost—SLCO2B1—female gonad—ovarian cancer	0.00745	0.0134	CbGeAlD
Latanoprost—SLC22A1—vagina—ovarian cancer	0.00708	0.0127	CbGeAlD
Latanoprost—SLCO2B1—testis—ovarian cancer	0.00661	0.0119	CbGeAlD
Latanoprost—Embolism—Paclitaxel—ovarian cancer	0.00599	0.0135	CcSEcCtD
Latanoprost—Keratitis—Paclitaxel—ovarian cancer	0.00593	0.0134	CcSEcCtD
Latanoprost—Dermatitis atopic—Paclitaxel—ovarian cancer	0.0052	0.0117	CcSEcCtD
Latanoprost—Embolism—Docetaxel—ovarian cancer	0.00508	0.0115	CcSEcCtD
Latanoprost—Dizziness—Altretamine—ovarian cancer	0.00498	0.0113	CcSEcCtD
Latanoprost—Toxic epidermal necrolysis—Chlorambucil—ovarian cancer	0.00491	0.0111	CcSEcCtD
Latanoprost—SLCO2B1—lymph node—ovarian cancer	0.00479	0.00859	CbGeAlD
Latanoprost—Eye irritation—Paclitaxel—ovarian cancer	0.0045	0.0102	CcSEcCtD
Latanoprost—Pain—Carboplatin—ovarian cancer	0.00445	0.0101	CcSEcCtD
Latanoprost—Dermatitis atopic—Docetaxel—ovarian cancer	0.0044	0.00996	CcSEcCtD
Latanoprost—Lacrimation increased—Paclitaxel—ovarian cancer	0.00417	0.00944	CcSEcCtD
Latanoprost—Eye irritation—Docetaxel—ovarian cancer	0.00382	0.00863	CcSEcCtD
Latanoprost—Dry eye—Paclitaxel—ovarian cancer	0.00355	0.00803	CcSEcCtD
Latanoprost—Lacrimation increased—Docetaxel—ovarian cancer	0.00354	0.008	CcSEcCtD
Latanoprost—Angina pectoris—Vinorelbine—ovarian cancer	0.00349	0.0079	CcSEcCtD
Latanoprost—Embolism—Epirubicin—ovarian cancer	0.00343	0.00774	CcSEcCtD
Latanoprost—Keratitis—Epirubicin—ovarian cancer	0.00339	0.00767	CcSEcCtD
Latanoprost—Inflammation—Docetaxel—ovarian cancer	0.00336	0.0076	CcSEcCtD
Latanoprost—Connective tissue disorder—Melphalan—ovarian cancer	0.00323	0.0073	CcSEcCtD
Latanoprost—Embolism—Doxorubicin—ovarian cancer	0.00317	0.00717	CcSEcCtD
Latanoprost—Keratitis—Doxorubicin—ovarian cancer	0.00314	0.00709	CcSEcCtD
Latanoprost—Eye pain—Paclitaxel—ovarian cancer	0.00309	0.00699	CcSEcCtD
Latanoprost—Mediastinal disorder—Topotecan—ovarian cancer	0.00303	0.00684	CcSEcCtD
Latanoprost—Dermatitis atopic—Epirubicin—ovarian cancer	0.00297	0.00672	CcSEcCtD
Latanoprost—Mediastinal disorder—Melphalan—ovarian cancer	0.00296	0.0067	CcSEcCtD
Latanoprost—Back pain—Topotecan—ovarian cancer	0.00283	0.00639	CcSEcCtD
Latanoprost—Connective tissue disorder—Vinorelbine—ovarian cancer	0.00282	0.00638	CcSEcCtD
Latanoprost—Dermatitis atopic—Doxorubicin—ovarian cancer	0.00275	0.00621	CcSEcCtD
Latanoprost—Stinging—Epirubicin—ovarian cancer	0.00271	0.00614	CcSEcCtD
Latanoprost—Mediastinal disorder—Vinorelbine—ovarian cancer	0.00259	0.00585	CcSEcCtD
Latanoprost—Toxic epidermal necrolysis—Paclitaxel—ovarian cancer	0.00251	0.00568	CcSEcCtD
Latanoprost—Stinging—Doxorubicin—ovarian cancer	0.00251	0.00568	CcSEcCtD
Latanoprost—Erythema—Vinorelbine—ovarian cancer	0.0025	0.00565	CcSEcCtD
Latanoprost—Arthralgia—Topotecan—ovarian cancer	0.00249	0.00562	CcSEcCtD
Latanoprost—Chest pain—Topotecan—ovarian cancer	0.00249	0.00562	CcSEcCtD
Latanoprost—Unspecified disorder of skin and subcutaneous tissue—Topotecan—ovarian cancer	0.00247	0.00559	CcSEcCtD
Latanoprost—Discomfort—Topotecan—ovarian cancer	0.00246	0.00556	CcSEcCtD
Latanoprost—Chest pain—Melphalan—ovarian cancer	0.00244	0.00551	CcSEcCtD
Latanoprost—Unspecified disorder of skin and subcutaneous tissue—Melphalan—ovarian cancer	0.00242	0.00547	CcSEcCtD
Latanoprost—Back pain—Vinorelbine—ovarian cancer	0.00242	0.00547	CcSEcCtD
Latanoprost—Lacrimation increased—Epirubicin—ovarian cancer	0.00239	0.00539	CcSEcCtD
Latanoprost—Nervous system disorder—Topotecan—ovarian cancer	0.00234	0.00529	CcSEcCtD
Latanoprost—Oedema—Melphalan—ovarian cancer	0.00234	0.00528	CcSEcCtD
Latanoprost—Bronchitis—Paclitaxel—ovarian cancer	0.00232	0.00525	CcSEcCtD
Latanoprost—Skin disorder—Topotecan—ovarian cancer	0.00232	0.00524	CcSEcCtD
Latanoprost—Pain—Chlorambucil—ovarian cancer	0.00229	0.00518	CcSEcCtD
Latanoprost—Skin disorder—Melphalan—ovarian cancer	0.00227	0.00513	CcSEcCtD
Latanoprost—Inflammation—Epirubicin—ovarian cancer	0.00227	0.00513	CcSEcCtD
Latanoprost—Upper respiratory tract infection—Paclitaxel—ovarian cancer	0.00224	0.00507	CcSEcCtD
Latanoprost—Lacrimation increased—Doxorubicin—ovarian cancer	0.00221	0.00499	CcSEcCtD
Latanoprost—Musculoskeletal discomfort—Topotecan—ovarian cancer	0.00217	0.00491	CcSEcCtD
Latanoprost—Toxic epidermal necrolysis—Docetaxel—ovarian cancer	0.00213	0.00482	CcSEcCtD
Latanoprost—Arthralgia—Vinorelbine—ovarian cancer	0.00213	0.00481	CcSEcCtD
Latanoprost—Chest pain—Vinorelbine—ovarian cancer	0.00213	0.00481	CcSEcCtD
Latanoprost—Musculoskeletal discomfort—Melphalan—ovarian cancer	0.00213	0.00481	CcSEcCtD
Latanoprost—Dyspnoea—Topotecan—ovarian cancer	0.00213	0.00481	CcSEcCtD
Latanoprost—Unspecified disorder of skin and subcutaneous tissue—Vinorelbine—ovarian cancer	0.00211	0.00478	CcSEcCtD
Latanoprost—Discomfort—Vinorelbine—ovarian cancer	0.0021	0.00475	CcSEcCtD
Latanoprost—Inflammation—Doxorubicin—ovarian cancer	0.0021	0.00474	CcSEcCtD
Latanoprost—Urinary tract infection—Paclitaxel—ovarian cancer	0.00209	0.00473	CcSEcCtD
Latanoprost—Conjunctivitis—Paclitaxel—ovarian cancer	0.00209	0.00473	CcSEcCtD
Latanoprost—Dyspnoea—Melphalan—ovarian cancer	0.00208	0.00471	CcSEcCtD
Latanoprost—Pain—Topotecan—ovarian cancer	0.00204	0.00461	CcSEcCtD
Latanoprost—Dry eye—Epirubicin—ovarian cancer	0.00203	0.00459	CcSEcCtD
Latanoprost—Nervous system disorder—Vinorelbine—ovarian cancer	0.002	0.00452	CcSEcCtD
Latanoprost—Pain—Melphalan—ovarian cancer	0.002	0.00451	CcSEcCtD
Latanoprost—Angina pectoris—Docetaxel—ovarian cancer	0.00199	0.0045	CcSEcCtD
Latanoprost—Skin disorder—Vinorelbine—ovarian cancer	0.00198	0.00448	CcSEcCtD
Latanoprost—Connective tissue disorder—Paclitaxel—ovarian cancer	0.0019	0.00429	CcSEcCtD
Latanoprost—Pruritus—Chlorambucil—ovarian cancer	0.0019	0.00429	CcSEcCtD
Latanoprost—Dry eye—Doxorubicin—ovarian cancer	0.00188	0.00425	CcSEcCtD
Latanoprost—Musculoskeletal discomfort—Vinorelbine—ovarian cancer	0.00186	0.0042	CcSEcCtD
Latanoprost—Hepatic function abnormal—Epirubicin—ovarian cancer	0.00183	0.00413	CcSEcCtD
Latanoprost—Dyspnoea—Vinorelbine—ovarian cancer	0.00182	0.00411	CcSEcCtD
Latanoprost—Eczema—Epirubicin—ovarian cancer	0.00178	0.00402	CcSEcCtD
Latanoprost—Conjunctivitis—Docetaxel—ovarian cancer	0.00177	0.00401	CcSEcCtD
Latanoprost—Eye pain—Epirubicin—ovarian cancer	0.00177	0.004	CcSEcCtD
Latanoprost—Pain—Vinorelbine—ovarian cancer	0.00174	0.00394	CcSEcCtD
Latanoprost—Mediastinal disorder—Paclitaxel—ovarian cancer	0.00174	0.00394	CcSEcCtD
Latanoprost—Hepatic function abnormal—Doxorubicin—ovarian cancer	0.00169	0.00382	CcSEcCtD
Latanoprost—Pruritus—Topotecan—ovarian cancer	0.00169	0.00381	CcSEcCtD
Latanoprost—Erythema—Paclitaxel—ovarian cancer	0.00168	0.0038	CcSEcCtD
Latanoprost—Pruritus—Melphalan—ovarian cancer	0.00165	0.00374	CcSEcCtD
Latanoprost—Eczema—Doxorubicin—ovarian cancer	0.00164	0.00372	CcSEcCtD
Latanoprost—Eye pain—Doxorubicin—ovarian cancer	0.00164	0.0037	CcSEcCtD
Latanoprost—Back pain—Paclitaxel—ovarian cancer	0.00163	0.00368	CcSEcCtD
Latanoprost—Connective tissue disorder—Docetaxel—ovarian cancer	0.00161	0.00364	CcSEcCtD
Latanoprost—Diplopia—Epirubicin—ovarian cancer	0.0016	0.00361	CcSEcCtD
Latanoprost—Vision blurred—Paclitaxel—ovarian cancer	0.00158	0.00358	CcSEcCtD
Latanoprost—Dizziness—Topotecan—ovarian cancer	0.00158	0.00357	CcSEcCtD
Latanoprost—Rash—Topotecan—ovarian cancer	0.0015	0.0034	CcSEcCtD
Latanoprost—Dermatitis—Topotecan—ovarian cancer	0.0015	0.0034	CcSEcCtD
Latanoprost—Headache—Topotecan—ovarian cancer	0.00149	0.00338	CcSEcCtD
Latanoprost—Diplopia—Doxorubicin—ovarian cancer	0.00148	0.00334	CcSEcCtD
Latanoprost—Mediastinal disorder—Docetaxel—ovarian cancer	0.00148	0.00334	CcSEcCtD
Latanoprost—Rash—Melphalan—ovarian cancer	0.00147	0.00333	CcSEcCtD
Latanoprost—Dermatitis—Melphalan—ovarian cancer	0.00147	0.00333	CcSEcCtD
Latanoprost—Pruritus—Vinorelbine—ovarian cancer	0.00144	0.00326	CcSEcCtD
Latanoprost—Toxic epidermal necrolysis—Epirubicin—ovarian cancer	0.00144	0.00325	CcSEcCtD
Latanoprost—Arthralgia—Paclitaxel—ovarian cancer	0.00143	0.00324	CcSEcCtD
Latanoprost—Chest pain—Paclitaxel—ovarian cancer	0.00143	0.00324	CcSEcCtD
Latanoprost—Erythema—Docetaxel—ovarian cancer	0.00143	0.00322	CcSEcCtD
Latanoprost—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—ovarian cancer	0.00142	0.00321	CcSEcCtD
Latanoprost—Discomfort—Paclitaxel—ovarian cancer	0.00141	0.0032	CcSEcCtD
Latanoprost—Asthma—Epirubicin—ovarian cancer	0.00138	0.00312	CcSEcCtD
Latanoprost—Back pain—Docetaxel—ovarian cancer	0.00138	0.00312	CcSEcCtD
Latanoprost—Oedema—Paclitaxel—ovarian cancer	0.00137	0.0031	CcSEcCtD
Latanoprost—Dizziness—Vinorelbine—ovarian cancer	0.00135	0.00305	CcSEcCtD
Latanoprost—Nervous system disorder—Paclitaxel—ovarian cancer	0.00135	0.00304	CcSEcCtD
Latanoprost—Angina pectoris—Epirubicin—ovarian cancer	0.00134	0.00304	CcSEcCtD
Latanoprost—Skin disorder—Paclitaxel—ovarian cancer	0.00133	0.00301	CcSEcCtD
Latanoprost—Toxic epidermal necrolysis—Doxorubicin—ovarian cancer	0.00133	0.00301	CcSEcCtD
Latanoprost—Bronchitis—Epirubicin—ovarian cancer	0.00133	0.003	CcSEcCtD
Latanoprost—Rash—Vinorelbine—ovarian cancer	0.00129	0.00291	CcSEcCtD
Latanoprost—Dermatitis—Vinorelbine—ovarian cancer	0.00129	0.00291	CcSEcCtD
Latanoprost—Upper respiratory tract infection—Epirubicin—ovarian cancer	0.00128	0.0029	CcSEcCtD
Latanoprost—Headache—Vinorelbine—ovarian cancer	0.00128	0.00289	CcSEcCtD
Latanoprost—Asthma—Doxorubicin—ovarian cancer	0.00128	0.00289	CcSEcCtD
Latanoprost—Musculoskeletal discomfort—Paclitaxel—ovarian cancer	0.00125	0.00283	CcSEcCtD
Latanoprost—Angina pectoris—Doxorubicin—ovarian cancer	0.00124	0.00281	CcSEcCtD
Latanoprost—Bronchitis—Doxorubicin—ovarian cancer	0.00123	0.00278	CcSEcCtD
Latanoprost—Dyspnoea—Paclitaxel—ovarian cancer	0.00122	0.00277	CcSEcCtD
Latanoprost—Arthralgia—Docetaxel—ovarian cancer	0.00121	0.00274	CcSEcCtD
Latanoprost—Chest pain—Docetaxel—ovarian cancer	0.00121	0.00274	CcSEcCtD
Latanoprost—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—ovarian cancer	0.0012	0.00272	CcSEcCtD
Latanoprost—Urinary tract infection—Epirubicin—ovarian cancer	0.0012	0.0027	CcSEcCtD
Latanoprost—Conjunctivitis—Epirubicin—ovarian cancer	0.0012	0.0027	CcSEcCtD
Latanoprost—Upper respiratory tract infection—Doxorubicin—ovarian cancer	0.00119	0.00268	CcSEcCtD
Latanoprost—Pain—Paclitaxel—ovarian cancer	0.00117	0.00265	CcSEcCtD
Latanoprost—Oedema—Docetaxel—ovarian cancer	0.00116	0.00263	CcSEcCtD
Latanoprost—Nervous system disorder—Docetaxel—ovarian cancer	0.00114	0.00258	CcSEcCtD
Latanoprost—Skin disorder—Docetaxel—ovarian cancer	0.00113	0.00255	CcSEcCtD
Latanoprost—Urinary tract infection—Doxorubicin—ovarian cancer	0.00111	0.0025	CcSEcCtD
Latanoprost—Conjunctivitis—Doxorubicin—ovarian cancer	0.00111	0.0025	CcSEcCtD
Latanoprost—Connective tissue disorder—Epirubicin—ovarian cancer	0.00109	0.00245	CcSEcCtD
Latanoprost—Musculoskeletal discomfort—Docetaxel—ovarian cancer	0.00106	0.0024	CcSEcCtD
Latanoprost—Dyspnoea—Docetaxel—ovarian cancer	0.00104	0.00234	CcSEcCtD
Latanoprost—Connective tissue disorder—Doxorubicin—ovarian cancer	0.001	0.00227	CcSEcCtD
Latanoprost—Mediastinal disorder—Epirubicin—ovarian cancer	0.000995	0.00225	CcSEcCtD
Latanoprost—Pain—Docetaxel—ovarian cancer	0.000995	0.00225	CcSEcCtD
Latanoprost—Pruritus—Paclitaxel—ovarian cancer	0.000971	0.00219	CcSEcCtD
Latanoprost—Erythema—Epirubicin—ovarian cancer	0.000961	0.00217	CcSEcCtD
Latanoprost—Back pain—Epirubicin—ovarian cancer	0.00093	0.0021	CcSEcCtD
Latanoprost—Mediastinal disorder—Doxorubicin—ovarian cancer	0.000921	0.00208	CcSEcCtD
Latanoprost—Dizziness—Paclitaxel—ovarian cancer	0.000907	0.00205	CcSEcCtD
Latanoprost—Vision blurred—Epirubicin—ovarian cancer	0.000906	0.00205	CcSEcCtD
Latanoprost—Erythema—Doxorubicin—ovarian cancer	0.000889	0.00201	CcSEcCtD
Latanoprost—Rash—Paclitaxel—ovarian cancer	0.000865	0.00196	CcSEcCtD
Latanoprost—Dermatitis—Paclitaxel—ovarian cancer	0.000864	0.00195	CcSEcCtD
Latanoprost—Back pain—Doxorubicin—ovarian cancer	0.00086	0.00195	CcSEcCtD
Latanoprost—Headache—Paclitaxel—ovarian cancer	0.00086	0.00194	CcSEcCtD
Latanoprost—Vision blurred—Doxorubicin—ovarian cancer	0.000838	0.0019	CcSEcCtD
Latanoprost—Pruritus—Docetaxel—ovarian cancer	0.000823	0.00186	CcSEcCtD
Latanoprost—Chest pain—Epirubicin—ovarian cancer	0.000818	0.00185	CcSEcCtD
Latanoprost—Arthralgia—Epirubicin—ovarian cancer	0.000818	0.00185	CcSEcCtD
Latanoprost—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—ovarian cancer	0.000813	0.00184	CcSEcCtD
Latanoprost—Discomfort—Epirubicin—ovarian cancer	0.000809	0.00183	CcSEcCtD
Latanoprost—Oedema—Epirubicin—ovarian cancer	0.000785	0.00177	CcSEcCtD
Latanoprost—Nervous system disorder—Epirubicin—ovarian cancer	0.000769	0.00174	CcSEcCtD
Latanoprost—Dizziness—Docetaxel—ovarian cancer	0.000769	0.00174	CcSEcCtD
Latanoprost—Skin disorder—Epirubicin—ovarian cancer	0.000762	0.00172	CcSEcCtD
Latanoprost—Arthralgia—Doxorubicin—ovarian cancer	0.000757	0.00171	CcSEcCtD
Latanoprost—Chest pain—Doxorubicin—ovarian cancer	0.000757	0.00171	CcSEcCtD
Latanoprost—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—ovarian cancer	0.000752	0.0017	CcSEcCtD
Latanoprost—Discomfort—Doxorubicin—ovarian cancer	0.000748	0.00169	CcSEcCtD
Latanoprost—Rash—Docetaxel—ovarian cancer	0.000733	0.00166	CcSEcCtD
Latanoprost—Dermatitis—Docetaxel—ovarian cancer	0.000733	0.00166	CcSEcCtD
Latanoprost—Headache—Docetaxel—ovarian cancer	0.000729	0.00165	CcSEcCtD
Latanoprost—Oedema—Doxorubicin—ovarian cancer	0.000726	0.00164	CcSEcCtD
Latanoprost—Musculoskeletal discomfort—Epirubicin—ovarian cancer	0.000715	0.00162	CcSEcCtD
Latanoprost—Nervous system disorder—Doxorubicin—ovarian cancer	0.000712	0.00161	CcSEcCtD
Latanoprost—Skin disorder—Doxorubicin—ovarian cancer	0.000705	0.00159	CcSEcCtD
Latanoprost—Dyspnoea—Epirubicin—ovarian cancer	0.000699	0.00158	CcSEcCtD
Latanoprost—Pain—Epirubicin—ovarian cancer	0.000671	0.00152	CcSEcCtD
Latanoprost—Musculoskeletal discomfort—Doxorubicin—ovarian cancer	0.000661	0.0015	CcSEcCtD
Latanoprost—Dyspnoea—Doxorubicin—ovarian cancer	0.000647	0.00146	CcSEcCtD
Latanoprost—Pain—Doxorubicin—ovarian cancer	0.000621	0.0014	CcSEcCtD
Latanoprost—Pruritus—Epirubicin—ovarian cancer	0.000555	0.00125	CcSEcCtD
Latanoprost—Dizziness—Epirubicin—ovarian cancer	0.000519	0.00117	CcSEcCtD
Latanoprost—Pruritus—Doxorubicin—ovarian cancer	0.000514	0.00116	CcSEcCtD
Latanoprost—Rash—Epirubicin—ovarian cancer	0.000495	0.00112	CcSEcCtD
Latanoprost—Dermatitis—Epirubicin—ovarian cancer	0.000494	0.00112	CcSEcCtD
Latanoprost—Headache—Epirubicin—ovarian cancer	0.000491	0.00111	CcSEcCtD
Latanoprost—Dizziness—Doxorubicin—ovarian cancer	0.00048	0.00109	CcSEcCtD
Latanoprost—Rash—Doxorubicin—ovarian cancer	0.000458	0.00103	CcSEcCtD
Latanoprost—Dermatitis—Doxorubicin—ovarian cancer	0.000457	0.00103	CcSEcCtD
Latanoprost—Headache—Doxorubicin—ovarian cancer	0.000455	0.00103	CcSEcCtD
